STAT

Before a biotech stock debacle, one Republican congressman made a prescient trade

Rep. John Culberson made a prescient sale to avoid losses when a tiny biotech's stock tanked. The stock was a favorite of several GOP representatives.
Rep. John Culberson made a prescient sale to avoid losses when a tiny biotech company's stock tanked.

A biotech stock meltdown last week led to huge paper losses for several congressional Republicans who had bought into the tiny company. But one politician-turned-investor was spared. Turns out, he had sold his shares just two weeks before news of a negative clinical trial decimated the company’s value.

Rep. John Culberson of Houston was among a half dozen House Republicans to invest in Innate Immunotherapeutics, an obscure Australian biotech company repeatedly

You're reading a preview, sign up to read more.

More from STAT

STAT9 min readScience
The ‘Unbelievable Journey’ Of CRISPR, Now On Netflix
"Unnatural Selection," a four-part docuseries debuting today, dissects the stories, science, and ethics behind genome editing.
STAT5 min read
Competitor Accuses 23andMe Of ‘False Negatives’ In Cancer-gene Testing
23andMe is pushing back hard on a new study from a competitor that accuses the company of 'false negatives' in its cancer-gene testing.
STAT4 min read
Opinion: As The Need For Organ Transplants Grows, The Number Of Transplant Physicians Dwindles
Medical training has been long been characterized as a "grand bargain" in which trainees make personal sacrifices with the expectation of a better life later. But that's a deal many…